Analysis
After 3 decades, denim giant Levi Strauss returns as a public company
After becoming a private company in 1985, the first blue jeans maker Levi Strauss returned to the public...
ADVERTISEMENT
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
2,203 articles
Analysis
Earnings preview: Pending deal with IBM puts spotlight on Red Hat’s Q4 report
Red Hat (RHT) has been drawing the attention of Wall Street ahead of its fourth-quarter report, due to...
Analysis
Guess? stock plunges as Q4 earnings miss estimates
Guess? Inc (GES) reported mixed results for its fourth quarter 2019. While earnings missed Street’s targets, revenue surpassed...
Analysis
Earnings Preview: Improved industry macros to help Canadian Solar in Q4
The solar industry has been affected across the board last year due to tariff wars between the US...
Analysis
What is NASH and which biotech firms are vying for the first-mover status
NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards...
Analysis
Earnings preview: Buyouts could drive Conagra Brands Q3 results
Conagra Brands (CAG) is scheduled to report its third-quarter results on Thursday before the market opens. The packaged...
Analysis
Earnings preview: Tiffany could take a beating from holiday slump, high costs in Q4
Tiffany & Co. (TIF), a leading manufacturer and retailer of designer jewelry, is scheduled to report the fourth-quarter...
Analysis
Earnings preview: Herman Miller to benefit from growing demand in Q3
The market is quite upbeat about the third-quarter financial performance of Herman Miller (MLHR), which is slated to...
Analysis
Earnings Preview: Strong subscriber growth to boost Zuora’s Q4 earnings
After the IPO in April 2018, shares of the subscription services provider Zuora (NYSE: ZUO) has been volatile...
Analysis
Earnings preview: Comps to drive Guess? Q4 results
Lifestyle products designer Guess? Inc. (GES) is scheduled to report its earnings for the fourth quarter on Wednesday...
Analysis
Earnings Preview: Aurinia’s Q4 results pivot on AURORA trial updates
Shares of Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) rose 13% on February 25 when the US patent office extended...
Analysis
Earnings preview Q4: Amyris likely to benefit from the new cannabinoid deal
Renewables product company Amyris (AMRS) is set to report its fourth quarter and full-year 2018 results on Monday,...